July 25, 2017 CLINICAL TRIAL FOR ASA/ASL TREATMENT OPEN FOR ENROLLMENT: The long-awaited clinical trial "Effect of Nitric Oxide Supplementation on Neurocognitive Functions in Patients With Argininosuccinate Lyase Deficiency/Argininosuccinic Aciduria (ASLD/ASA)" is now open for enrollment at Baylor College of Medicine (one of the UCD Research Consortium clinical research sites) in Houston, Texas. A result of their pioneering discovery on the role of the urea cycle in regulating nitric oxide in the human body, the study is being conducted by Dr. Sandesh Nagamani and Dr. Brendan Lee to assess the effects of nitric oxide supplementation on general cognition, memory, executive functioning, and fine motor functioning in individuals with ASLD. DETAILS AND ELIGIBILITY
